Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BASIC2: Exenatide and Family-Based Treatment for Childhood Obesity
NCT04520490Phase 3Active, not recruiting
- Sponsor
- Seattle Children's
- Start
- Jan 2021
- Primary completion
- Aug 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of exenatide in childhood obesity, sponsored by Seattle Children's. Started Jan 2021; status: active, not recruiting.
02
Drugs
exenatide
03
Conditions
childhood obesity
Beyond the preview
Go deeper on NCT04520490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04520490.